scholarly journals Comparative antimicrobial efficacy study of different commercially available toothpaste in India: An in vitro study

2021 ◽  
pp. 122-131
Keyword(s):  
In Vitro Study ◽  
Chemotherapeutic Agents ◽  
Oral Bacteria ◽  
Oral Microbiome ◽  
Antimicrobial Efficacy ◽  
Bacteria Growth ◽  
E Coli ◽  
Test Organisms ◽  
Oral Pathogens

Antimicrobial chemotherapeutic agents have been recommended for lowering oral bacteria growth. The main purpose of this study is to examine the efficacy of different toothpaste formulations in providing complete oral cavity protection against oral pathogens. By using a modified well agar diffusion assay, twenty kinds of toothpaste were examined for antimicrobial efficacy against two oral pathogens: Streptococcus aureus and Escherichia coli. The examination indicated that the majority of the non-herbal dentifrices and combinations of herbal and chemical-based dentifrices chosen for the investigation were viable against both microbial strains, however, to differing degrees. TP1 and TP17 were found the best against E. coli and S. aureus, respectively, with 21.553 mm and 23.443 mm as the zone of inhibition. From the herbal dentifrices, TP15 was found to have significant effect on E. coli, followed by TP19 for S. aureus. Nevertheless, toothpaste TP15 and TP19 were not effective against S. aureus and E. coli, respectively. In correlation, the inhibition zones of every single other dentifrice were found to be less. Antimicrobial activity against test organisms was stronger in a sodium lauryl sulphate-based dental formulations, when combined with fluoride. A formulation including TP15 exhibited substantial activity against the tested bacterium E. coli among herbal dentifrices. Statistical analysis demonstrated that the effectiveness against Gram-negative bacteria was greater than against Gram-positive bacteria. Furthermore, herbal toothpaste can be incorporated with chemotherapeutic agents to enhance its effectiveness against pathogens present in the oral microbiome. This comparison aids in the identification of the toothpaste’s shortcomings and benefits over other formulations, widening the scope of more potent toothpaste products.

scholarly journals Antimicrobial efficacy of a new tri-antibiotic combination against resistant endodontic pathogens: An in-vitro study

2020 ◽  
Vol 23 (4) ◽  
pp. 8p ◽  
Author(s):  
Prasanna T. Dahake ◽  
Sudhindra M Baliga
Keyword(s):  
Root Canal ◽  
Pathogenic Bacteria ◽  
Culture Media ◽  
In Vitro Study ◽  
Vitro Study ◽  
New Combination ◽  
Antimicrobial Efficacy ◽  
E Coli ◽  
Background Removal

Background: Removal of all the pathogenic bacteria from the root canal system is of prime importance for the success of endodontic therapy. Objective: The study aimed to determine the antimicrobial efficacy of three antibiotics and their new combination against selected endodontic pathogens. Methods: In this in-vitro study, we used bacterial strains associated with the refractory endodontic condition and determined MIC and MBC of Clindamycin (C), Metronidazole (M), Doxycycline (D) as well as their combination CMD. We cultured Candida Albicans, Pseudomonas Aeruginosa, Escherichia Coli, Enterococcus Faecalis, Streptococcus Mutans, Bacillus Subtilis subsp. spizizenii, Actinomyces Actinomycetemcomitans on selective culture media. We analyzed the data using paired 't' test, one-way ANOVA, and Tuckey's HSD post hoc test. Results: Clindamycin inhibited the growth of C. Albicans (90%) and S. Mutans (90%) significantly and P. Aeruginosa, E. Coli, E. Faecalis, B. Subtilis, and A. Actinomycetemcomitans were resistant to it. Metronidazole did not inhibit any of the bacteria. Doxycycline inhibited C. Albicans (90%), P. Aeruginosa (90%), and S. Mutans (90%) significantly while E. Coli, E. Faecalis, B. Subtilis, and A. Actinomycetemcomitans were resistant to it. The combination of CMD inhibited all the microbes significantly. However, at bactericidal concentrations of CMD, E. Faecalis (p = 0.024), B. Subtilis (p = 0.021) and A. Actinomycetemcomitans (p = 0.041) were eliminated significantly, while C. Albicans (p = 0.164), P. Aeruginosa (p = 0.489), E. Coli (p = 0.106) and S. Mutans (p = 0.121) showed resistance. Conclusion: Combination CMD can be used against resistant endodontic pathogens to achieve predictable endodontic results.KEYWORDSAntimicrobial agents; Clindamycin; Doxycycline; Metronidazole; Root canal therapy.    

scholarly journals A Evaluate the biological activity of Citrullus Colocynthis extract (In vitro study)

2021 ◽  
Vol 26 (4) ◽  
Author(s):  
HAYDER YOUSIF ◽  
Zahraa F Shaker ◽  
Hayder Hamed Abed
Keyword(s):  
Staphylococcus Aureus ◽  
Pathogenic Bacteria ◽  
Antibacterial Properties ◽  
Water Extract ◽  
In Vitro Study ◽  
Ethanolic Extract ◽  
Citrullus Colocynthis ◽  
E Coli ◽  
Test Organisms

The plant of c. colocynthis is perennial herbal of the Cucurbitaceous types that isused as a traditional medicinal plant on a Mediterranean tub and equatorialnations.Studies on the antibacterial properties of Citrullus colocynthis leaf extract,Medicinal plants have conventional been used in abortifacient and treatsconstipation, edema, Infection caused by bacteria, cancer and diabetesproblems.The antibacterial efficacy of citrullus colocynthesis (L.) was investigatedin this work using five species of pathogenic bacteria isolated from urinary tractinfections: E. coli, Klebsiella pneumoniae, Streptococcus spp, Psudomonasauroginosa, and Staphylococcus aureus. For the antibacterial test, water andethanol extract were employed.The ethanolic extract showed inhibitory activityagainst Escherichia Coli at (100 °C, 80 °C, 60 °C) while Staphylococcus aureus at(100 °C, 80 °C), Streptococcus spp. at (100 °C). Water extract exhibited less or noactivity against all types of bacteria.The findings of this investigation indicate thatC. colocynthis might be utilized to treat disorders caused by the test organisms.

Acetate Kinase (AcK) is Essential for Microbial Growth and Betel-derived Compounds Potentially Target AcK, PhoP and MDR Proteins in M. tuberculosis, V. cholerae and Pathogenic E. coli: An in silico and in vitro Study

2019 ◽  
Vol 18 (31) ◽  
pp. 2731-2740 ◽  
Author(s):  
Sandeep Tiwari ◽  
Debmalya Barh ◽  
M. Imchen ◽  
Eswar Rao ◽  
Ranjith K. Kumavath ◽  
...  
Keyword(s):  
Broad Spectrum ◽  
In Silico ◽  
Pathogenic Bacteria ◽  
In Vitro Study ◽  
Docking Studies ◽  
Acetate Kinase ◽  
E Coli ◽  
Pathogenic Escherichia Coli ◽  
Novel Target

Background: Mycobacterium tuberculosis, Vibrio cholerae, and pathogenic Escherichia coli are global concerns for public health. The emergence of multi-drug resistant (MDR) strains of these pathogens is creating additional challenges in controlling infections caused by these deadly bacteria. Recently, we reported that Acetate kinase (AcK) could be a broad-spectrum novel target in several bacteria including these pathogens. Methods: Here, using in silico and in vitro approaches we show that (i) AcK is an essential protein in pathogenic bacteria; (ii) natural compounds Chlorogenic acid and Pinoresinol from Piper betel and Piperidine derivative compound 6-oxopiperidine-3-carboxylic acid inhibit the growth of pathogenic E. coli and M. tuberculosis by targeting AcK with equal or higher efficacy than the currently used antibiotics; (iii) molecular modeling and docking studies show interactions between inhibitors and AcK that correlate with the experimental results; (iv) these compounds are highly effective even on MDR strains of these pathogens; (v) further, the compounds may also target bacterial two-component system proteins that help bacteria in expressing the genes related to drug resistance and virulence; and (vi) finally, all the tested compounds are predicted to have drug-like properties. Results and Conclusion: Suggesting that, these Piper betel derived compounds may be further tested for developing a novel class of broad-spectrum drugs against various common and MDR pathogens.

Sign in / Sign up

Export Citation Format

Share Document